To evaluate the efficiency of this treatment, the SDAV was initially tittered with the EerI inhibitor at concentrations of 5 μM/mL and 25 μM/mL and, again, using a collected cell medium (after 24 h course of infection) to ascertain whether VCP inhibition by EerI influenced SDAV egress from neurons (Figure 9A,B). Here, VCP is linked to infection.